{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T08:34:20Z","timestamp":1792917260094,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T00:00:00Z","timestamp":1438732800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s12020-015-0702-y","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T07:57:49Z","timestamp":1438675069000},"page":"488-494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Role of 68Ga-DOTATATE PET\/CT in patients with multiple endocrine neoplasia type 1 (MEN1)"],"prefix":"10.1007","volume":"52","author":[{"given":"Secondo","family":"Lastoria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Marciello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antongiulio","family":"Faggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Aloj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corradina","family":"Carac\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Aurilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"D\u2019Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Di Gennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Ramundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Camera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Fonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,5]]},"reference":[{"key":"702_CR1","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"R.V. Thakker, P.J. Newey, G.V. Walls, J. Bilezikian, H. Dralle, P.R. Ebeling, S. Melmed, A. Sakurai, F. Tonelli, M.L. Brandi, Endocrine society: clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J. Clin. Endocrinol. Metab. 97, 2990\u20133011 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"702_CR2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1055\/s-0031-1286324","volume":"43","author":"V Ramundo","year":"2011","unstructured":"V. Ramundo, F. Milone, R. Severino, S. Savastano, C. Di Somma, L. Vuolo, L. De Luca, G. Lombardi, A. Colao, A. Faggiano, Clinical and prognostic implications of the genetic diagnosis of hereditary NET syndromes in asymptomatic patients. Horm. Metab. Res. 43, 794\u2013800 (2011)","journal-title":"Horm. Metab. Res."},{"key":"702_CR3","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.3748\/wjg.v16.i36.4519","volume":"16","author":"M Imamura","year":"2010","unstructured":"M. Imamura, Recent standardization of treatment strategy for pancreatic neuroendocrine tumors. World J. Gastroenterol. 16, 4519\u20134525 (2010)","journal-title":"World J. Gastroenterol."},{"key":"702_CR4","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1148\/rg.306105523","volume":"30","author":"RB Lewis","year":"2010","unstructured":"R.B. Lewis, G.E. Lattin Jr, E. Paal, Pancreatic endocrine tumors: radiologic-clinicopathologic correlation. Radiographics 30, 1445\u20131464 (2010)","journal-title":"Radiographics"},{"key":"702_CR5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","volume":"20","author":"EP Krenning","year":"1993","unstructured":"E.P. Krenning, D.J. Kwekkeboom, W.H. Bakker, W.A. Breeman, P.P. Kooij, H.Y. Oei, M. van Hagen, P.T. Postema, M. de Jong, J.C. Reubi et al., Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur. J. Nucl. Med. 20, 716\u2013731 (1993)","journal-title":"Eur. J. Nucl. Med."},{"key":"702_CR6","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s002590100639","volume":"28","author":"M Hofmann","year":"2001","unstructured":"M. Hofmann, H. Maecke, R. B\u00f6rner, E. Weckesser, P. Sch\u00f6ffski, L. Oei, J. Schumacher, M. Henze, A. Heppeler, J. Meyer, H. Knapp, Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data. Eur. J. Nucl. Med. 28, 1751\u20131757 (2001)","journal-title":"Eur. J. Nucl. Med."},{"key":"702_CR7","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/cncr.23469","volume":"112","author":"I Kayani","year":"2008","unstructured":"I. Kayani, J.B. Bomanji, A. Groves, G. Conway, S. Gacinovic, T. Win, J. Dickson, M. Caplin, P.J. Ell, Functional imaging of neuroendocrine tumors with combined PET\/CT using 68Ga-DOTATATE (DOTA-DPhe1, Tyr3-octreotate) and 18F-FDG. Cancer 112, 2447\u20132455 (2008)","journal-title":"Cancer"},{"key":"702_CR8","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s00259-010-1512-3","volume":"37","author":"I Virgolini","year":"2010","unstructured":"I. Virgolini, V. Ambrosini, J.B. Bomanji, R.P. Baum, S. Fanti, M. Gabriel, N.D. Papathanasiou, G. Pepe, W. Oyen, C. De Cristoforo, A. Chiti, Procedure guidelines for PET\/CT tumor imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. Eur. J. Nucl. Med. Mol. Imaging 37, 2004\u20132010 (2010)","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"702_CR9","first-page":"4087","volume":"27","author":"A Al-Nahhas","year":"2007","unstructured":"A. Al-Nahhas, Z. Win, T. Szyszko, A. Singh, C. Nanni, S. Fanti, D. Rubello, Gallium-68 PET: a new frontier in receptor cancer imaging. Anticancer Res. 27, 4087\u20134094 (2007)","journal-title":"Anticancer Res."},{"key":"702_CR10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/1078-0432.1136.11.3","volume":"11","author":"M Ginj","year":"2005","unstructured":"M. Ginj, J. Chen, M.A. Walter, V. Eltschinger, J.C. Reubi, H.R. Maecke, Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy. Clin. Cancer. Res. 11, 1136\u20131145 (2005)","journal-title":"Clin. Cancer. Res."},{"key":"702_CR11","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00259-003-1255-5","volume":"30","author":"D Wild","year":"2003","unstructured":"D. Wild, J.S. Schmitt, M. Ginj, H.R. M\u00e4cke, B.F. Bernard, E. Krenning, M. De Jong, S. Wenger, J.C. Reubi, DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals. Eur. J. Nucl. Med. Mol. Imaging 30, 1338\u20131347 (2003)","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"702_CR12","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s12149-012-0634-z","volume":"26","author":"V Froeling","year":"2012","unstructured":"V. Froeling, F. Elgeti, M.H. Maurer, C. Scheurig-Muenkler, A. Beck, T.J. Kroencke, U.F. Pape, B. Hamm, W. Brenner, N.F. Schreiter, Impact of Ga-68 DOTATOC PET\/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia. Ann. Nucl. Med. 26, 738\u2013743 (2012)","journal-title":"Ann. Nucl. Med."},{"key":"702_CR13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1754-9485.2011.02327.x","volume":"56","author":"MS Hofman","year":"2012","unstructured":"M.S. Hofman, G. Kong, O.C. Neels, P. Eu, E. Hong, R.J. Hicks, High management impact of Ga-68 DOTATATE (GaTate) PET\/CT for imaging neuroendocrine and other somatostatin expressing tumours. J. Med. Imaging. Radiat. Oncol. 56, 40\u201347 (2012)","journal-title":"J. Med. Imaging. Radiat. Oncol."},{"key":"702_CR14","first-page":"762","volume":"40","author":"DJ Kwekkeboom","year":"1999","unstructured":"D.J. Kwekkeboom, P.P. Kooij, W.H. Bakker, H.R. M\u00e4cke, E.P. Krenning, Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptake. J. Nucl. Med. 40, 762\u2013767 (1999)","journal-title":"J. Nucl. Med."},{"key":"702_CR15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1089\/cbr.2006.325","volume":"22","author":"C Wehrmann","year":"2007","unstructured":"C. Wehrmann, S. Senftleben, C. Zachert, D. M\u00fcller, R.P. Baum, Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC. Cancer Biother. Radiopharm. 22, 406\u2013416 (2007)","journal-title":"Cancer Biother. Radiopharm."},{"key":"702_CR16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.5812\/ijem.4313","volume":"10","author":"S Kumar Gupta","year":"2012","unstructured":"S. Kumar Gupta, S. Singla, N.A. Damle, K. Agarwal, C. Bal, Diagnosis of Men-I syndrome on (68)Ga-DOTANOC PET-CT and role of peptide receptor radionuclide therapy with (177)Lu-DOTATATE. Int. J Endocrinol. Metab. 10, 629\u2013633 (2012)","journal-title":"Int. J Endocrinol. Metab."},{"key":"702_CR17","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00268-012-1539-7","volume":"36","author":"MA Lewis","year":"2012","unstructured":"M.A. Lewis, G.B. Thompson, W.F. Young Jr, Preoperative assessment of the pancreas in multiple endocrine neoplasia type 1. World J. Surg. 36, 1375\u20131381 (2012)","journal-title":"World J. Surg."},{"key":"702_CR18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1102\/1470-7330.2004.0008","volume":"4","author":"A McLean","year":"2004","unstructured":"A. McLean, Endoscopic ultrasound in the detection of pancreatic islet cell tumors. Cancer Imaging 4, 84\u201391 (2004)","journal-title":"Cancer Imaging"},{"key":"702_CR19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1259\/bjr\/85014761","volume":"85","author":"S Philips","year":"2012","unstructured":"S. Philips, S.N. Shah, R. Vikram, S. Verma, A.K. Shanbhogue, S.R. Prasad, Pancreatic endocrine neoplasms: a current update on genetics and imaging. Br. J. Radiol. 85, 682\u2013696 (2012)","journal-title":"Br. J. Radiol."},{"key":"702_CR20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.dld.2011.09.014","volume":"44","author":"C Barbe","year":"2012","unstructured":"C. Barbe, A. Murat, B. Dupas, P. Ruszniewski, A. Tabarin, M.P. Vullierme, A. Penfornis, V. Rohmer, E. Baudin, M. Le Rhun, D. Gaye, C. Marcus, G. Cadiot, Groupe d\u2019\u00e9tude des Tumeurs Endocrines (GTE), Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumors in multiple endocrine neoplasia type 1. Dig. Liver. Dis. 44, 228\u2013234 (2012)","journal-title":"Dig. Liver. Dis."},{"key":"702_CR21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s11547-011-0636-2","volume":"116","author":"L Camera","year":"2011","unstructured":"L. Camera, S. Paoletta, C. Mollica, F. Milone, V. Napolitano, L. De Luca, A. Faggiano, A. Colao, M. Salvatore, Screening of pancreaticoduodenal endocrine tumors in patients with MEN 1: multidetector-row computed tomography vs. endoscopic ultrasound. Radiol. Med. 116, 595\u2013606 (2011)","journal-title":"Radiol. Med."},{"key":"702_CR22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0720-048X(01)00354-0","volume":"39","author":"R Gao","year":"2001","unstructured":"R. Gao, H. Isoda, T. Tanaka, S. Inagawa, H. Takeda, Y. Takehara, S. Isogai, H. Sakahara, Dynamic gadolinium-enhanced MR imaging of pituitary adenomas: usefulness of sequential sagittal and coronal plane images. Eur. J. Radiol. 39, 139\u2013146 (2001)","journal-title":"Eur. J. Radiol."},{"key":"702_CR23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s11604-012-0117-0","volume":"30","author":"N Naswa","year":"2012","unstructured":"N. Naswa, C.J. Das, P. Sharma, S. Karunanithi, C. Bal, R. Kumar, Ectopic pituitary adenoma with empty sella in the setting of MEN-1 syndrome: detection with 68Ga-DOTANOC PET\/CT. Jpn. J. Radiol. 30, 783\u2013786 (2012)","journal-title":"Jpn. J. Radiol."},{"key":"702_CR24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/2156-7514.102053","volume":"2","author":"S Piciucchi","year":"2012","unstructured":"S. Piciucchi, D. Barone, G. Gavelli, A. Dubini, D. Oboldi, F. Matteuci, Primary hyperparathyroidism: imaging to pathology. J. Clin. Imaging Sci. 2, 59 (2012)","journal-title":"J. Clin. Imaging Sci."},{"key":"702_CR25","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1365-2265.2008.03301.x","volume":"69","author":"A Faggiano","year":"2008","unstructured":"A. Faggiano, L.B. Tavares, L. Tauchmanova, F. Milone, G. Mansueto, V. Ramundo, M.L. De Caro, G. Lombardi, G. De Rosa, A. Colao, Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients. Clin. Endocrinol. 69, 756\u2013762 (2008)","journal-title":"Clin. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0702-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-015-0702-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0702-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T20:32:54Z","timestamp":1691872374000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-015-0702-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["702"],"URL":"https:\/\/doi.org\/10.1007\/s12020-015-0702-y","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,5]]}}}